Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 108
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Health in Hands: ONBOARD (H2O)- An Exhibition cum workshop for popularizing pharmaceutical science and its impact on the health among school children | Dr N Krishna Veni, Professor and HOD, JSS College of Pharmacy, Tamil Nadu | 2020 | Department of Science and Technology (DST), Govt. of India | Science Popularisation |
| Antibody-based capture of 2019-nCoV and its inactivation using lipid-based in situ gel | Dr. Kiran Kondabagil, Associate Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Design of novel bactericidal molecules targeting a conserved bacterial transcription regulator | Dr Ranjan Sen, Scientist, Centre for DNA Fingerprinting and Diagnostics (CDFD), Telangana | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug design |
| Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug discovery |
| Determination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections | Dr Gopal Chandra Kundu, Scientist & Director, National Centre for Cell Science (NCCS), Maharashtra | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Pharmacodynamics |
| Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF), USA | Filariasis; Biostatistics |
| Centre of Excellence for Epilepsy - Phase - II | Dr. Manjari Tripathi, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi, Dr. Tapan Kumar Gandhi, Associate Professor, Indian Institute of Technology (IIT), Delhi, Dr. Pravat Mandal, Professor, National Brain Research Centre (NBRC), Gurugram | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy | Dr. C Gopi Mohan, Associate Professor, Amrita Vishwa Vidyapeetham Amritapuri Campus (AVVAC), Kollam | 2018 | Department of Biotechnology (DBT), Government of India, New Delhi | Adjuvant therapy |
| Engagement of Clinical Development Services Agency (CDSA) for monitoring cum management of clinical cohort study (ADBS) at NIMHANS, Bengaluru | Prof. Apurva Sarin, Professor, Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Dr. Nitya Wadhwa, Assistant Professor, Translational Health Science and Technology Institute (THSTI), Faridabad | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Healthcare Technology Innovation Centre (HTIC)-Phase II | Dr. Mohanasankar Sivaprakasam, Associate Professor, Indian Institute of Technology (IIT), Chennai | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |